Chief Business & Investment Officer, Co-founder
Rowan has over 30 years of experience working in innovative businesses applying computational methods to life science and patient data to understand disease and find new medicines and treatments for unmet medical needs. She is an experienced entrepreneur and advisor to fast growing companies and is a Co-founder and Chief Business and Investment Officer of PrecisionLife, expanding precision medicine in chronic disease.
She is a non-executive director of STFC Innovations, which is the commercialization and technology transfer arm for the Science and Technology Facilities Council (STFC), helping move scientific research and intellectual property out of the lab and into the commercial market.
She was formerly a board member of Digital Health and Care Wales a strategic health authority tasked with the digital transformation of NHS in Wales. She was responsible for oversight and assurance of information governance and cyber security as Chair of the digital governance and safety board sub-committee.
Rowan holds a Masters in biochemistry from the University of Oxford and played a part in one of the university's first spinouts, Oxford Molecular Group, when it listed on the London Stock Exchange in 1994. She collaborated with the pioneering team at CERN to disseminate the applications to cloud computing frameworks in healthcare and pharmaceutical research. She has served on various grant awarding juries including Cartier Women’s Initiative and most recently SPRIN-D’s Continuous Hormone Monitoring Challenge.
